GINA NICKELS-NELSON: Open Payments
NPI 1376526921 · TYLER, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,496 in 61 payments from 14 companies in 2025. Trend: 2023 $306 · 2024 $1,448 · 2025 $1,496
Food & beverage: $1,397Education: $99
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 15 | $472 |
| GlaxoSmithKline, LLC. | 19 | $257 |
| Regeneron Healthcare Solutions, Inc. | 8 | $250 |
| Takeda Pharmaceuticals U.S.A., Inc. | 5 | $149 |
| GENZYME CORPORATION | 3 | $96 |
| Lilly USA, LLC | 2 | $49 |
| CSL Behring | 1 | $46 |
| BioCryst US Sales Co., LLC | 2 | $39 |
| ARS Pharmaceuticals Operations, Inc. | 1 | $29 |
| Lundbeck LLC | 1 | $25 |
Products named: DUPIXENT, TRELEGY ELLIPTA, AIRSUPRA, TEZSPIRE, CUVITRU, AYVAKIT, TALTZ, Privigen.
Industry payments across TX — which companies pay providers there.
